Electrical Equipment & Parts
Compare Stocks
2 / 10Stock Comparison
NVT vs EMR
Revenue, margins, valuation, and 5-year total return — side by side.
Industrial - Machinery
NVT vs EMR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Electrical Equipment & Parts | Industrial - Machinery |
| Market Cap | $26.96B | $79.02B |
| Revenue (TTM) | $4.33B | $18.32B |
| Net Income (TTM) | $492M | $2.44B |
| Gross Margin | 37.0% | 52.7% |
| Operating Margin | 15.8% | 19.8% |
| Forward P/E | 39.7x | 21.7x |
| Total Debt | $1.56B | $13.76B |
| Cash & Equiv. | $238M | $1.54B |
NVT vs EMR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| nVent Electric plc (NVT) | 100 | 909.6 | +809.6% |
| Emerson Electric Co. (EMR) | 100 | 231.2 | +131.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: NVT vs EMR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
NVT is the clearest fit if your priority is growth exposure and long-term compounding.
- Rev growth 29.5%, EPS growth 118.8%, 3Y rev CAGR 19.3%
- 5.8% 10Y total return vs EMR's 206.6%
- Lower volatility, beta 1.68, Low D/E 41.8%, current ratio 1.63x
EMR carries the broadest edge in this set and is the clearest fit for income & stability and defensive.
- Dividend streak 37 yrs, beta 1.52, yield 1.5%
- Beta 1.52, yield 1.5%, current ratio 0.88x
- Lower P/E (21.7x vs 39.7x)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 29.5% revenue growth vs EMR's 3.0% | |
| Value | Lower P/E (21.7x vs 39.7x) | |
| Quality / Margins | 13.3% margin vs NVT's 11.4% | |
| Stability / Safety | Beta 1.52 vs NVT's 1.68 | |
| Dividends | 1.5% yield, 37-year raise streak, vs NVT's 0.5% | |
| Momentum (1Y) | +178.6% vs EMR's +30.4% | |
| Efficiency (ROA) | 7.2% ROA vs EMR's 5.8%, ROIC 8.9% vs 8.2% |
NVT vs EMR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
NVT vs EMR — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
EMR leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
EMR is the larger business by revenue, generating $18.3B annually — 4.2x NVT's $4.3B. Profitability is closely matched — net margins range from 13.3% (EMR) to 11.4% (NVT). On growth, NVT holds the edge at +53.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $4.3B | $18.3B |
| EBITDAEarnings before interest/tax | $848M | $4.7B |
| Net IncomeAfter-tax profit | $492M | $2.4B |
| Free Cash FlowCash after capex | $387M | $3.1B |
| Gross MarginGross profit ÷ Revenue | +37.0% | +52.7% |
| Operating MarginEBIT ÷ Revenue | +15.8% | +19.8% |
| Net MarginNet income ÷ Revenue | +11.4% | +13.3% |
| FCF MarginFCF ÷ Revenue | +8.9% | +17.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | +53.5% | +2.9% |
| EPS Growth (YoY)Latest quarter vs prior year | -59.7% | +28.2% |
Valuation Metrics
EMR leads this category, winning 6 of 6 comparable metrics.
Valuation Metrics
At 34.9x trailing earnings, EMR trades at a 10% valuation discount to NVT's 38.7x P/E. On an enterprise value basis, EMR's 18.1x EV/EBITDA is more attractive than NVT's 34.3x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $27.0B | $79.0B |
| Enterprise ValueMkt cap + debt − cash | $28.3B | $91.2B |
| Trailing P/EPrice ÷ TTM EPS | 38.68x | 34.92x |
| Forward P/EPrice ÷ next-FY EPS est. | 39.70x | 21.71x |
| PEG RatioP/E ÷ EPS growth rate | — | 7.73x |
| EV / EBITDAEnterprise value multiple | 34.30x | 18.07x |
| Price / SalesMarket cap ÷ Revenue | 6.93x | 4.39x |
| Price / BookPrice ÷ Book value/share | 7.36x | 3.94x |
| Price / FCFMarket cap ÷ FCF | 72.49x | 29.63x |
Profitability & Efficiency
NVT leads this category, winning 8 of 9 comparable metrics.
Profitability & Efficiency
NVT delivers a 13.4% return on equity — every $100 of shareholder capital generates $13 in annual profit, vs $12 for EMR. NVT carries lower financial leverage with a 0.42x debt-to-equity ratio, signaling a more conservative balance sheet compared to EMR's 0.68x. On the Piotroski fundamental quality scale (0–9), EMR scores 7/9 vs NVT's 6/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +13.4% | +12.1% |
| ROA (TTM)Return on assets | +7.2% | +5.8% |
| ROICReturn on invested capital | +8.9% | +8.2% |
| ROCEReturn on capital employed | +10.5% | +10.0% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 7 |
| Debt / EquityFinancial leverage | 0.42x | 0.68x |
| Net DebtTotal debt minus cash | $1.3B | $12.2B |
| Cash & Equiv.Liquid assets | $238M | $1.5B |
| Total DebtShort + long-term debt | $1.6B | $13.8B |
| Interest CoverageEBIT ÷ Interest expense | 6.61x | 6.46x |
Total Returns (Dividends Reinvested)
NVT leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in NVT five years ago would be worth $53,671 today (with dividends reinvested), compared to $15,945 for EMR. Over the past 12 months, NVT leads with a +178.6% total return vs EMR's +30.4%. The 3-year compound annual growth rate (CAGR) favors NVT at 59.8% vs EMR's 20.7% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +56.5% | +4.3% |
| 1-Year ReturnPast 12 months | +178.6% | +30.4% |
| 3-Year ReturnCumulative with dividends | +308.2% | +75.9% |
| 5-Year ReturnCumulative with dividends | +436.7% | +59.5% |
| 10-Year ReturnCumulative with dividends | +576.7% | +206.6% |
| CAGR (3Y)Annualised 3-year return | +59.8% | +20.7% |
Risk & Volatility
Evenly matched — NVT and EMR each lead in 1 of 2 comparable metrics.
Risk & Volatility
EMR is the less volatile stock with a 1.52 beta — it tends to amplify market swings less than NVT's 1.68 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NVT currently trades 95.5% from its 52-week high vs EMR's 85.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.68x | 1.52x |
| 52-Week HighHighest price in past year | $174.50 | $165.15 |
| 52-Week LowLowest price in past year | $59.73 | $108.37 |
| % of 52W HighCurrent price vs 52-week peak | +95.5% | +85.4% |
| RSI (14)Momentum oscillator 0–100 | 82.3 | 61.3 |
| Avg Volume (50D)Average daily shares traded | 2.3M | 2.8M |
Analyst Outlook
EMR leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Wall Street rates NVT as "Buy" and EMR as "Buy". Consensus price targets imply 14.8% upside for EMR (target: $162) vs -19.6% for NVT (target: $134). For income investors, EMR offers the higher dividend yield at 1.49% vs NVT's 0.48%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $134.00 | $161.92 |
| # AnalystsCovering analysts | 17 | 41 |
| Dividend YieldAnnual dividend ÷ price | +0.5% | +1.5% |
| Dividend StreakConsecutive years of raises | 2 | 37 |
| Dividend / ShareAnnual DPS | $0.79 | $2.10 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.9% | +1.6% |
EMR leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). NVT leads in 2 (Profitability & Efficiency, Total Returns). 1 tied.
NVT vs EMR: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is NVT or EMR a better buy right now?
For growth investors, nVent Electric plc (NVT) is the stronger pick with 29.
5% revenue growth year-over-year, versus 3. 0% for Emerson Electric Co. (EMR). Emerson Electric Co. (EMR) offers the better valuation at 34. 9x trailing P/E (21. 7x forward), making it the more compelling value choice. Analysts rate nVent Electric plc (NVT) a "Buy" — based on 17 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — NVT or EMR?
On trailing P/E, Emerson Electric Co.
(EMR) is the cheapest at 34. 9x versus nVent Electric plc at 38. 7x. On forward P/E, Emerson Electric Co. is actually cheaper at 21. 7x.
03Which is the better long-term investment — NVT or EMR?
Over the past 5 years, nVent Electric plc (NVT) delivered a total return of +436.
7%, compared to +59. 5% for Emerson Electric Co. (EMR). Over 10 years, the gap is even starker: NVT returned +576. 7% versus EMR's +206. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — NVT or EMR?
By beta (market sensitivity over 5 years), Emerson Electric Co.
(EMR) is the lower-risk stock at 1. 52β versus nVent Electric plc's 1. 68β — meaning NVT is approximately 10% more volatile than EMR relative to the S&P 500. On balance sheet safety, nVent Electric plc (NVT) carries a lower debt/equity ratio of 42% versus 68% for Emerson Electric Co. — giving it more financial flexibility in a downturn.
05Which is growing faster — NVT or EMR?
By revenue growth (latest reported year), nVent Electric plc (NVT) is pulling ahead at 29.
5% versus 3. 0% for Emerson Electric Co. (EMR). On earnings-per-share growth, the picture is similar: nVent Electric plc grew EPS 118. 8% year-over-year, compared to 17. 8% for Emerson Electric Co.. Over a 3-year CAGR, NVT leads at 19. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — NVT or EMR?
nVent Electric plc (NVT) is the more profitable company, earning 18.
2% net margin versus 12. 7% for Emerson Electric Co. — meaning it keeps 18. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: EMR leads at 19. 6% versus 15. 8% for NVT. At the gross margin level — before operating expenses — EMR leads at 52. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is NVT or EMR more undervalued right now?
On forward earnings alone, Emerson Electric Co.
(EMR) trades at 21. 7x forward P/E versus 39. 7x for nVent Electric plc — 18. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for EMR: 14. 8% to $161. 92.
08Which pays a better dividend — NVT or EMR?
All stocks in this comparison pay dividends.
Emerson Electric Co. (EMR) offers the highest yield at 1. 5%, versus 0. 5% for nVent Electric plc (NVT).
09Is NVT or EMR better for a retirement portfolio?
For long-horizon retirement investors, Emerson Electric Co.
(EMR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (1. 5% yield, +206. 6% 10Y return). nVent Electric plc (NVT) carries a higher beta of 1. 68 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (EMR: +206. 6%, NVT: +576. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between NVT and EMR?
Both stocks operate in the Industrials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: NVT is a mid-cap high-growth stock; EMR is a mid-cap quality compounder stock. EMR pays a dividend while NVT does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.